key: cord-0968369-kz1lv602 authors: Park, Ae Kyung; Kim, Il-Hwan; Kim, Junyoung; Kim, Jeong-Min; Kim, Heui Man; Lee, Chae young; Han, Myung-Guk; Rhie, Gi-Eun; Kwon, Donghyok; Nam, Jeong-Gu; Park, Young-Joon; Gwack, Jin; Lee, Nam-Joo; Woo, SangHee; No, Jin Sun; Lee, Jaehee; Ha, Jeemin; Rhee, JeeEun; Yoo, Cheon-Kwon; Kim, Eun-Jin title: Genomic Surveillance of SARS-CoV-2: Distribution of Clades in the Republic of Korea in 2020 date: 2021-02-03 journal: Osong Public Health Res Perspect DOI: 10.24171/j.phrp.2021.12.1.06 sha: 2d23ecadeab1ff9b47ddbafed083eb0233061874 doc_id: 968369 cord_uid: kz1lv602 Since a novel beta-coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, there has been a rapid global spread of the virus. Genomic surveillance was conducted on samples isolated from infected individuals to monitor the spread of genetic variants of SARS-CoV-2 in Korea. The Korea Disease Control and Prevention Agency performed whole genome sequencing of SARS-CoV-2 in Korea for 1 year (January 2020 to January 2021). A total of 2,488 SARS-CoV-2 cases were sequenced (including 648 cases from abroad). Initially, the prevalent clades of SARS-CoV-2 were the S and V clades, however, by March 2020, GH clade was the most dominant. Only international travelers were identified as having G or GR clades, and since the first variant 501Y.V1 was identified (from a traveler from the United Kingdom on December 22(nd), 2020), a total of 27 variants of 501Y.V1, 501Y.V2, and 484K.V2 have been classified (as of January 25(th), 2021). The results in this study indicated that quarantining of travelers entering Korea successfully prevented dissemination of the SARS-CoV-2 variants in Korea. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in December 2019, in Wuhan, China, and subsequently, the virus has spread rapidly all over the world [1] . Since the first novel coronavirus genome sequence was made available (January 10 th , 2020 [2] ), whole genome sequencing (WGS) has been extensively performed globally, to † These authors contributed equally to this work. [3] . Detection of novel variants of SARS-CoV-2 including 501Y.V1 (also known as Variant of Concern 2020/12/01) [4] , 501Y.V2 [5] and 484K.V2 [6] , which have rapidly spread worldwide, have emphasized the need for sequence-based strain surveillance, to promptly detect mutations to prevent the spread of new variants. The Republic of Korea was one of the first countries to report a significant Coronavirus Disease-19 (COVID-19) outbreak which was managed successfully due to the effective cooperation between the government and the people of Korea. As part of a comprehensive national surveillance of COVID-19, the Korea Disease Control and Prevention Agency (KDCA) conducted the WGS of SARS-CoV-2 using real-time genomic epidemiology data to monitor how the virus mutates, and correlates with sequence variation since the first case of SARS-CoV-2 infection was identified in Korea on January 20 th , 2020 [7] . In this Brief Report, the SARS-CoV-2 genomes of 2,488 confirmed cases in Korea were sequenced and analyzed, in the context of the global viral population, from the beginning of the pandemic to provide valuable insights into the genetic pattern of SARS-CoV-2 distribution in Korea. Nasopharyngeal and oropharyngeal swabs were collected from SARS-CoV-2, real-time reverse transcription (RT)-PCR confirmed cases. RNA extraction and RT-PCR were performed on the samples from the swabs, according to the methods described in a previous report [8] . To perform WGS, cDNA was amplified using primer pools Since A total of 2,488 SARS-CoV-2 were sequenced during the period between January 20 th , 2020 and January 25 th (2, 021 including 648 cases imported from abroad). The overall distribution of clades over time is shown in Figure 3A . There was an initial period during January to March 2020 when the S and V clades (GISAID nomenclatures) were more prevalent in total than G/GR/GH clades in Korea ( Figure 3B ). S and V clades were the most prevalent clades at the beginning of the epidemic however, after the emergence of the variant D614G spike protein mutation, this variant became predominant [10] . Multiple SARS-CoV-2 variants have been circulating globally. In January 2020, following the first case of COVID-19 in Furthermore, genomic surveillance has also played a crucial role in monitoring recent variants including 501Y.V1, 501Y. V2, and 484K.V2. To date these variants of SARS-CoV-2 have not been introduced and spread in Korea, indicating that the quarantine and containment strategy was effective. Despite several sharp spikes in the number of confirmed COVID-19 cases in Korea in 2020, the cooperation between the Korean government and the general population has enabled a successful 3T strategy (Test, Trace, and Treat) for containing the COVID-19 pandemic. The KDCA will continue to contribute to a global effort to better understand, treat, and prevent COVID-19. The authors have no conflicts of interest to declare. A pneumonia outbreak associated with a new coronavirus of probable bat origin A new coronavirus associated with human respiratory disease in China Global initiative on sharing all influenza datafrom vision to reality Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Viological.org: 2020 Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa Genomic characterisation of an emergent SARS-CoV-2 lineage in Manaus: Preliminary findings. Viological.org: 2020 The First Case of 2019 Novel Coronavirus Pneumonia Imported into Korea from Wuhan, China: implication for infection prevention and control measures Identification of Coronavirus Isolated from a Patient in Korea with COVID-19 Genomic investigation of the coronavirus disease-2019 outbreak in the Republic of Korea Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology Data, disease, and diplomacy: GISAID's innovative contribution to global health An interactive web-based dashboard to track COVID-19 in real time We are grateful to all the contributions from the laboratories responsible for obtaining the specimens and all the laboratories where genetic sequence data were generated, and shared via the GISAID, on which this research is based. Special thanks to the Emergency Operation Center of the KDCA for its great effort in recording new confirmed cases.This study was funded by Korea Disease Control and Prevention Agency (no.: 4800-4837-301, 4800-4834-303).